Snapshot · Danaher Corporation (DHR)

Sector: Healthcare / Medical - Diagnostics & Research

229.04-1.06%

Data as of 2026-10-18T09:43:37.205Z

Fundamentals check

Market cap
$161.0B
P/E (TTM)
40.5
Gross margin
58.5%
Net margin
15.9%
ROE
7.7%
R&D / revenue
6.4%
Dividend yield
0.7%
FCF yield
3.4%

Latest dividend: $0.4/share (ex-date 2026-09-30, quarterly)

Summary

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

How it makes money

Revenue mix, latest fiscal year

  • Revenue from Contract with Customer, Measurement, Recurring81.9%
  • Revenue from Contract with Customer, Measurement, Nonrecurring18.1%

Recent Events

  • 2026-10-01T00:00:00.000Znegative

    Price move: DHR fell 4.4%

    DHR 在这段行情中出现明显波动,恰逢异常的价格变动,但此处没有可关联到的具体新闻事件。

  • 2026-09-15T00:00:00.000Zpositive

    Price move: DHR rose 3.0%

    DHR 在这段行情中出现明显波动,恰逢异常的价格变动,但此处没有可关联到的具体新闻事件。

  • 2026-09-01T00:00:00.000Znegative

    Price move: DHR fell 3.1%

    DHR 在这段行情中出现明显波动,恰逢异常的价格变动,但此处没有可关联到的具体新闻事件。

  • 2026-08-21T03:47:31.000Zneutral

    Bank of New York Mellon Corp Purchases New Position in Danaher Corporation $DHR

    银行业投资者增持 Danaher 可能与股价波动相关,但无法确认因果关系,属于市场动态的潜在驱动因素。

    Source: defenseworld.net

  • 2026-08-19T00:00:00.000Zpositive

    Price move: DHR rose 6.0%

    DHR 在这段行情中出现明显波动,恰逢异常的价格变动,但此处没有可关联到的具体新闻事件。

  • 2026-07-21T00:00:00.000Znegative

    Price move: DHR fell 11.0%

    DHR 在这段行情中出现明显波动,恰逢异常的价格变动,但此处没有可关联到的具体新闻事件。

Price & event timeline

Price & event timeline

Three months of price history with annotated events to help spot what may have driven a move.

筹码分布

242.12
240.75
239.39
238.02
236.66
235.30
233.93
232.57
231.20
229.84
228.47
227.11
225.74
224.38
223.01
221.65
220.29
218.92
217.56
216.19
214.83
213.46
212.10
210.73
209.37
208.01
206.64
205.28
203.91
202.55
201.18
199.82
198.45
197.09
195.72
194.36
193.00
191.63
190.27
188.90
187.54
186.17
184.81
183.44
182.08
180.72
179.35
177.99
176.62
175.26
173.89
172.53
171.16
169.80
168.43
167.07
165.71
164.34
162.98
161.61
获利盘 94.7%现价 229.04

资金流指标

以下为基于公开量价数据的技术指标估算,非真实主力资金流。

Analyst view

Wall Street ratings

Strong buy 1Buy 29Hold 12Sell 1

Avg price target $228.89 from 9 analysts (last quarter)

Insider & Congress activity

聪明钱动向 · 近 90 天

内部人净卖出 ▼0 人买 / 3 人卖 · 净 -58,255 股
国会议员均衡0 人买 / 0 人卖 · 净 +$0

内部人近 90 天整体偏卖出,国会议员披露无相关交易。

Open-market trades only; grants and exercises excluded

  • 2026-08-21SellBlair Rainer(director, officer: President & CEO)7,755 shares
  • 2026-08-21SellBlair Rainer(director, officer: President & CEO)39,193 shares
  • 2026-08-21SellBlair Rainer(director, officer: President & CEO)11,307 shares

Go deeper

订阅每日简报

每个交易日开盘/收盘后,中文市场简报直达邮箱。免费,随时退订。

本内容仅为信息整理,不构成任何投资建议。

Deep analysis

Deep analysis

Generate a full in-page analysis (business model, risks, scenarios). Not investment advice.

Disclaimer

This content is for informational purposes only and is not investment advice.